Icecure Medical Ltd Ordinary Shares ICCM 深 滬
已收盤 07-25 16:00:00 美东时间
1.07
+0.085
+8.63%
華盛通- 最 高1.21
- 今 開1.14
- 成交量 3921.09万股
- 最 低 0.96
- 昨 收 0.985
- 總市值 6400.87万
- 52周最高 1.6288
- 市盈率 靜 --
- 換手率 65.55%
- 52周最低 0.471
- 委 比 53.49%
- 總股本 5982.12万
- 歷史最高 12.167
- 量 比 89.96
- 振 幅 25.38%
- 歷史最低 0.471
- 每 手 1
- 風險率 0.27%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多IceCure Medical ProSense Featured At Japanese Breast Cancer Society Conference
Breast surgeon, Professor Eisuke Fukuma, a highly regarded cryoablation expert & ProSense® user at Kameda Medical Center, presented updated breast cancer cryoablation data from an independent study of over
07-25 21:03
IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period
CAESAREA, Israel, July 24, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology t...
07-24 21:00
IceCure Medical Announces Shareholder Meeting for August 2025
Icecure Medical ( ($ICCM) ) just unveiled an update. IceCure Medical Ltd. has a...
07-17 04:37
IceCure Medical Launches $10M Rights Offering To Fund Operations, Repay Bridge Loan
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal,
07-10 20:08
IceCure Announces Commencement of Rights Offering
CAESAREA, Israel, July 10, 2025 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology t...
07-10 20:00
IceCure Medical Launches $10M Rights Offering At $1.00/Unit; Company's Largest Shareholder, Epoch Commits Up To $5M
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal,
06-25 21:27
IceCure Medical Secures U.S. Patent Allowance for Cryogen Flow Control
An update from Icecure Medical ( ($ICCM) ) is now available. On June 9, 2025, I...
06-09 20:57
美股大行评级 | 潜在涨幅746.15%！Intrusion获Ascendiant Capital升目标价至11美元，维持"买入"评级
潜在涨幅746.15%！Intrusion获Ascendiant Capital升目标价至11美元，维持"买入"评级
06-02 13:32
美股大行评级 | 英伟达、赛富时、C3.ai、Veeva Systems等获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Cogent Biosciences(COGT)"超配"评级，目标价从21美元升至25美元</p> <p>• Chardan Capital：维持Taysha Gene Therapies(TSHA)"买入"
05-30 09:09
HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $2.5 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $2.5 price target.
05-30 00:10
